FDA Week - 11/09/2018

FDA, DOD Sign Agreement To Approve Medical Products For Military

November 02, 2018
A new relationship between FDA and the Department of Defense (DOD) went official Friday (Nov. 2) with the announcement of a memorandum of agreement (MOU) that will formalize a framework agreed upon in January, under which FDA will work with DOD to accelerate access to medical products for the military. The agreement came the same day that FDA approved a highly controversial fentanyl product, which DOD helped develop and said was a high priority drug for the battlefield. FDA now...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.